Clinical Trial Update: A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing aerosolized pentamidine to parenteral/oral trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Pneumocystis Pneumonia

Drugs mentioned

• Aerosolized pentamidine (pentamidine)
• trimethoprim-sulfamethoxazole (TMP-SMX) (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED